Alterations of the nuclear transport system in hepatocellular carcinoma - New 
basis for therapeutic strategies

Beck, Martin; Schirmacher, Peter; Singer, Stephan

doi:10.1016/j.jhep.2017.06.021

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Alterations of the nuclear transport system in hepatocellular carcinoma - New basis for therapeutic strategies

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Beck, M., Schirmacher, P., & Singer, S. (2017). Alterations of the nuclear transport system in hepatocellular carcinoma - New basis for therapeutic strategies. Journal of Hepatology, 67(5), 1051-1061. doi:10.1016/j.jhep.2017.06.021.

Cite as: https://hdl.handle.net/21.11116/0000-0006-A198-8

Abstract

Hepatocellular carcinoma (HCC) is among the most prevalent human malignancies worldwide with rising incidence in industrialised countries, few therapeutic options and poor prognosis. To expand and improve therapeutic strategies, identification of drug targets involved in several liver cancer-related pathways is crucial. Virtually all signal transduction cascades cross the nuclear envelope and therefore require components of the nuclear transport system (NTS), including nuclear transport receptors (e.g. importins and exportins) and the nuclear pore complex. Accordingly, members of the NTS represent promising targets for therapeutic intervention. Selective inhibitors of nuclear export have already entered clinical trials for various malignancies. Herein, we review the current knowledge regarding alterations of the NTS and their potential for targeted therapy in HCC.